EUCTR2013-002034-21-AT进行中（未招募）1 期
Diacerein for the treatment of Epidermolysis bullosa simplex - Diacerein for EBS
EB House Austria0 个研究点开始时间: 2013年8月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Epidermolysis bullos simplex - type Dowling-Meara
- •- Mutations in either the keratin 14 or the keratin 5 gene, leading to protein aggregation
- •- Age: 6-19
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 14
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Other types of EB with mutations in the keratin 14 or teh keratin 5 gene.
- •- participation in another clinical trial at the same time
- •- known intolerance against diacerein, adjuvants (especially Tartrazine) or other substances with similar structures
- •- pregnancy or lactation
- •- relevant other illnesses (acute infections, ...)
- •- patients with impaired liver functions
研究者
相似试验
已完成
2 期
Diacerein for the treatment of epidermolysis bullosa simplexQ81.0Epidermolysis bullosa simplexDRKS00005412Division of Experimental Dermatology and EB House AustriaDepartment of DermatologyUniversity Hospital SalzburgParacelsus Medical UniversityUniversity Hospital for Dermatology17
进行中（未招募）
不适用
Diacerein for the treatment of atopic dermatitisAtopic dermatitisEUCTR2014-005593-11-ATniversity Hospital of Dermatology, Paracelsus Medical University
Unknown
2 期
Diacerin for the Treatment of Epidermolysis Bullosa SimplexEpidermolysis Bullosa SimplexNCT02470689Tel-Aviv Sourasky Medical Center50
已完成
不适用
Treatment of the skin manifestations of Darier's disease by the topical application of COX-2 inhibitorsDarier's diseaseJPRN-UMIN000015905Department of Dermatology, Keio University School of Medicine10
进行中（未招募）
不适用
BOSENTAN FOR THE TREATMENT OF SKIN ULCERS IN DIABETICMICROANGIOPATHYBosentan for the treatment of skin ulcera in diabetic MicroangiopathyEUCTR2011-001736-30-ATMed. Univ. Wien, Klinik für Dermatologie40